SAB Biotherapeutics, Inc. (SABSW) stock
SABSWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SABS
$0.01+0.00 (+33.33%)
Close on Oct 20, 2026Market cap $304.80MP/E –Yield –
SAB Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
SAB Biotherapeutics's market cap was $217.08M on Oct 19, 2026, against $30.20M a year earlier. Over the last 5 years it ranged from $12.63M to $380.64M, with a median of $55.40M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $217.08M | +22.2% |
| 2025 | Dec 31, 2025 | $177.63M | +407.3% |
| 2024 | Dec 31, 2024 | $35.02M | -44.8% |
| 2023 | Dec 29, 2023 | $63.48M | +41.7% |
| 2022 | Dec 30, 2022 | $44.80M | -1.3% |
| 2021 | Dec 31, 2021 | $45.37M | – |